PN-943
Protagonist Therapeutics, Inc.
['ibd']
the ideal trial, pn-943 in mod-sev uc, an oral gut-restrictive alfa4beta7 integrin peptide antagonist.
presented by walter reinisch #ibd #uegweek #uegweek22 
Celebrate life. Gastroenterologist. IBD. WGH Edinburgh/Zaragoza-Spain.I share my slides in @ibdeii